You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AN05

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Scalp Seborrheic Dermatitis Trial in Worldwide (clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week),

Completed
Has Results
  • Scalp Seborrheic Dermatitis
  • clobetasol propionate shampoo (4/week) - ketoconazole shampoo (2/week)
  • +3 more
  • Brugge, Belgium
  • +17 more
Feb 16, 2021

Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)

Recruiting
  • Diffuse Astrocytoma
  • +22 more
  • Phoenix, Arizona
  • +26 more
Jan 27, 2023

Alzheimer's Disease Conversion Rate Differences Between

Completed
  • Mild Cognitive Impairment
  • Usual care setting
  • Anyang, Korea, Republic of
  • +15 more
Oct 5, 2021

Overactive Bladder (OAB), Pharmacokinetics of Mirabegron Trial in Worldwide (Mirabegron, Placebo)

Recruiting
  • Overactive Bladder (OAB)
  • Pharmacokinetics of Mirabegron
  • Edegem, Belgium
  • +34 more
Nov 28, 2022

Renal Cell Carcinoma, Metastatic Trial in Worldwide (Intuvax (INN: ilixadencel), Sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma, Metastatic
  • Chicago, Illinois
  • +27 more
Jul 23, 2022

Psoriatic Arthritis Trial in Australia, Spain, United States (TILD sub-cutaneous (SC) injection)

Active, not recruiting
  • Psoriatic Arthritis
  • TILD sub-cutaneous (SC) injection
  • Covina, California
  • +30 more
Aug 5, 2022

Lyme Disease Trial in Worldwide (VLA15, Saline)

Not yet recruiting
  • Lyme Disease
  • VLA15
  • Saline
  • New London, Connecticut
  • +25 more
Aug 2, 2022

Advanced Solid Tumors Trial in Worldwide (PDR001)

Recruiting
  • Advanced Solid Tumors
  • New York, New York
  • +42 more
Jan 23, 2023

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PD-1 inhibitor, Tenofovir Disoproxil)

Recruiting
  • Hepatitis B, Chronic
  • Vancouver, British Columbia, Canada
  • +31 more
Jan 17, 2023

Dry Eye Disease Trial in United States (SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium

Completed
  • Dry Eye Disease
  • SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate)
  • +6 more
  • Phoenix, Arizona
  • +39 more
Apr 10, 2022

Renal Impairment, Healthy Volunteer Trial in Worldwide (BMS-986165)

Completed
  • Renal Impairment
  • Healthy Volunteer
  • Orlando, Florida
  • +5 more
Mar 10, 2021

Hemophilia A Trial in Worldwide (BAX 888)

Active, not recruiting
  • Hemophilia A
  • BAX 888
  • Phoenix, Arizona
  • +15 more
Nov 23, 2021

COPD (COPD) Trial in Worldwide (BGF MDI HFO 320/14.4/9.6 µg, BGF MDI HFA 320/14.4/9.6 µg)

Recruiting
  • Chronic Obstructive Pulmonary Disease (COPD)
  • BGF MDI HFO 320/14.4/9.6 μg
  • BGF MDI HFA 320/14.4/9.6 μg
  • Phoenix, Arizona
  • +96 more
Jan 23, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Non Small Cell Lung Carcinoma NSCLC Trial in Worldwide (Durvalumab (MEDI4736), Paclitaxel + carboplatin, Gemcitabine +

Active, not recruiting
  • Non Small Cell Lung Carcinoma NSCLC
  • Durvalumab (MEDI4736)
  • +5 more
  • Anaheim, California
  • +92 more
Jan 31, 2023

Psoriasis Trial in Winston-Salem (Internet Survey, fluocinonide 0.05% ointment)

Completed
Has Results
  • Psoriasis
  • Internet Survey
  • fluocinonide 0.05% ointment
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences Department of Dermatology
May 18, 2020

Advanced Solid Tumors Cancer Trial in Worldwide (Osimertinib, Nivolumab, Telisotuzumab vedotin)

Recruiting
  • Advanced Solid Tumors Cancer
  • Scottsdale, Arizona
  • +35 more
Jan 12, 2023

Cancer Trial in Worldwide (Trametinib, Dabrafenib)

Completed
Has Results
  • Cancer
  • Phoenix, Arizona
  • +15 more
Jun 21, 2021

Cerebral Palsy, Dyskinetic Trial in Worldwide (TEV-50717)

Recruiting
  • Cerebral Palsy, Dyskinetic
  • Birmingham, Alabama
  • +33 more
Feb 13, 2022

Liver Dysfunction, Liver Insufficiency, Hepatic Failure Trial in Hungary, Poland (BMS-986231)

Completed
  • Liver Dysfunction
  • +6 more
  • Budapest, Hungary
  • +3 more
Aug 26, 2020

Urinary Tract Infections Trial in Worldwide (Gepotidacin, Placebo matching nitrofurantoin, Nitrofurantoin)

Completed
  • Urinary Tract Infections
  • Birmingham, Alabama
  • +103 more
Dec 14, 2022

Spasticity Trial in Worldwide (IPN10200, Placebo, Dysport)

Recruiting
  • Spasticity
  • IPN10200
  • +2 more
  • Linz, Austria
  • +40 more
Dec 16, 2022

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-428, Nivolumab)

Completed
  • Advanced Solid Tumors Cancer
  • Scottsdale, Arizona
  • +14 more
Jul 17, 2020

Neovascular Age-related Macular Degeneration Trial in Worldwide (brolucizumab)

Active, not recruiting
  • Neovascular Age-related Macular Degeneration
  • Huntington Beach, California
  • +59 more
Jan 20, 2023

Moderate-to-severe Atopic Dermatitis Trial in China (CBP-201, Placebo)

Recruiting
  • Moderate-to-severe Atopic Dermatitis
  • Hefei, Anhui, China
  • +55 more
Sep 22, 2021